From: Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections
Patient (Pn)
Group
Breakthrough time (Week)
Mutation
Rescue therapy
P1
LDT
36
M204I
LDT + ADV
P2
52
P3
M204V
P4
L180M
P5
TDF
P6